1 |
Hofmann GE, Abramowicz JS. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet Gynecol Scand 1990;69:217-21.
DOI
|
2 |
Caplan MS, Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001;13:111-5.
DOI
|
3 |
Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364: 255-64.
DOI
|
4 |
Stey A, Barnert ES, Tseng CH, Keeler E, Needleman J, Leng M, et al. Outcomes and costs of surgical treatments of necrotizing enterocolitis. Pediatrics 2015;135:e1190-7.
DOI
|
5 |
Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008; 32:70-82.
DOI
|
6 |
Cho SX, Berger PJ, Nold-Petry CA, Nold MF. The immunological landscape in necrotising enterocolitis. Expert Rev Mol Med 2016;18:e12.
DOI
|
7 |
Bradshaw WT. Necrotizing enterocolitis: etiology, presentation, management, and outcomes. J Perinat Neonatal Nurs 2009;23:87-94.
DOI
|
8 |
Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015;314:1039-51.
DOI
|
9 |
Young C, Sharma R, Handfield M, Mai V, Neu J. Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention? Pediatr Res 2009;65(5 Pt 2):91R-97R.
DOI
|
10 |
Filleur S, Nelius T, de Riese W, Kennedy RC. Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem 2009;106: 769-75.
DOI
|
11 |
Dvorak B, Halpern MD, Holubec H, Williams CS, McWilliam DL, Dominguez JA, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002;282:G156-64.
DOI
|
12 |
Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987;17:213-88.
|
13 |
Playford RJ, Wright NA. Why is epidermal growth factor present in the gut lumen? Gut 1996;38:303-5.
DOI
|
14 |
Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res 2003;284:2-13.
DOI
|
15 |
Guo J, Sheng G, Warner BW. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells. J Biol Chem 2005;280: 35992-8.
DOI
|
16 |
Basuroy S, Seth A, Elias B, Naren AP, Rao R. MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J 2006;393(Pt 1):69-77.
DOI
|
17 |
Mannon P, Reinisch W. Interleukin 13 and its role in gut defence and inflammation. Gut 2012;61:1765-73.
DOI
|
18 |
Elliott SN, Wallace JL, McKnight W, Gall DG, Hardin JA, Olson M, et al. Bacterial colonization and healing of gastric ulcers: the effects of epidermal growth factor. Am J Physiol Gastrointest Liver Physiol 2000;278:G105-12.
DOI
|
19 |
Shin CE, Falcone RA Jr, Stuart L, Erwin CR, Warner BW. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 2000;35:173-6.
DOI
|